NEW YORK (GenomeWeb News) – Targets of the FOXP2 transcription factor appear to be under strong, positive selective pressure in European populations, researchers led by the Wellcome Trust Sanger Institute's Chris Tyler-Smith reported in an online, early American Journal of Human Genetics article yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.